Enclomiphene Overview

This article applies specifically to the Enclomiphene treatment plan.

Requirements may differ for other Maximus programs.
​
​The Enclomiphene protocol supports the body’s natural testosterone production by stimulating hormonal signaling between the brain and the testes.

Unlike testosterone replacement therapy (TRT), which introduces external testosterone, enclomiphene works by encouraging the body to produce more of its own testosterone.

Your clinician evaluates your symptoms, hormone levels, medical history, and goals to determine whether this protocol may be appropriate.

The primary medication used in this protocol is enclomiphene, a medication that influences hormonal signaling involved in testosterone production.

In some cases, clinicians may also recommend supportive treatments or combination approaches depending on individual health goals.

Your clinician determines the appropriate treatment plan based on your health profile and clinical evaluation.

Testosterone production is regulated by a signaling pathway between the brain and the testes known as the hypothalamic–pituitary–gonadal (HPG) axis.

Enclomiphene works by influencing this signaling pathway.

By adjusting how estrogen receptors communicate with the brain, enclomiphene can encourage the body to increase natural testosterone production.

This approach may support testosterone levels while maintaining the body’s natural hormone regulation.

The Enclomiphene protocol may be appropriate for individuals who:

Eligibility is determined by your clinician based on lab results, symptoms, and medical history.

This protocol may not be appropriate for individuals with certain health conditions or hormone profiles.

Your clinician evaluates factors such as:

This evaluation helps determine whether enclomiphene is the right approach.